Dr M Raja is biomedical researcher and did his doctorate from JSS Academy of Higher Education and Research, Mysuru [2022]. He had undertaken research in area of nano-based drug delivery system for cancer. He was granted with patent in preparation and evaluation of nanoparticles and had publication in reputed journals. He possess teaching experience in the capacity of Associate Professor and engaged in development of products in herbal practices. He is involved in evaluation of potential unique practices in validation and product development activities.
Articles
Raja, M., Raman S. (2022) Recent Trends in Carbon Nanotubes Based Prostate Cancer
Therapy: A Biomedical Hybrid for Diagnosis and Treatment. Current drug delivery, 19(2), 229-
237.
Raja, M., Raman S., Yuvaraj, H., & Sibi, L. (2021). Ibrutinib conjugated surface-
functionalized multiwalled carbon nanotubes and its biopolymer composites for targeting
prostate carcinoma. Journal of Materials science, 56, 18684-18696.
Raja, M,. Sureshkumar, R., Srikanth, J., Manisha, C., & Arun R. (2021). Multiwalled carbon
nanotubes as nanomaterial tool in the management of prostate cancer: A possible nano
formulation approach. Advanced Pharmaceutical bulletin, 12(3), 509-514.
Book Chapter
Raja Murugesan (2021). Advanced characterizations and techniques in book entitled
‘2D Functional nanomaterials: Synthesis, characterization and applications, Wiley-
VCH GmbH, ISSN: 9783-5273-46-776.
Patent
Raja, M., Sureshkumar, R. (2021). Ibrutinib loaded onto multiwalled carbon
nanotubes and conjugated with T30 oligonucleotide. Patent Application
No:202141040144.
Raja, M. (2017). Preparation and evaluation of nanoparticles containing imatinib
mesylate and the complex of imatinib mesylate cobalt (II) chloride”. Patent
Application No:201741025589.
